SEARCH RESULTS

16355 RESULTS

Derek Narendra


National Institutes of Health
Besthesda, United States

Phase 3 Trial Suggests Pimavanserin Assuages Psychosis in Dementia

RESEARCH NEWS 2019-09-18 Research News A Phase 3 trial of pimavanserin was halted early when the study met its primary endpoint of delaying relapse to psychosis in people with dementia, according to a press release  by its sponsor, Acadia Pharmaceuticals. Pimavanserin —a ...

Sam Cohen


Wren Therapeutics
Cambridge, United Kingdom

Current Filters

  • Date Range : Sep 2018 to Sep 2019 x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE